Global Anti-Venom Market Growth 2022-2028
As the global economy mends, the 2021 growth of Anti-Venom will have significant change from previous year. According to our latest study, the global Anti-Venom market size is USD million in 2022 from USD 938.3 million in 2021, with a change of % between 2021 and 2022. The global Anti-Venom market size will reach USD 1264.8 million in 2028, growing at a CAGR of 4.4% over the analysis period.
The United States Anti-Venom market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Venom market, reaching US$ million by the year 2028. As for the Europe Anti-Venom landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti-Venom players cover CSL, Merck, BTG, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Venom market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Polyvalent Anti-Venom
Monovalent Anti-Venom
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Non-profit Institutions
Hospitals and Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Venom Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Venom by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Venom by Country/Region, 2017, 2022 & 2028
2.2 Anti-Venom Segment by Type
2.2.1 Polyvalent Anti-Venom
2.2.2 Monovalent Anti-Venom
2.3 Anti-Venom Sales by Type
2.3.1 Global Anti-Venom Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Venom Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Venom Sale Price by Type (2017-2022)
2.4 Anti-Venom Segment by Application
2.4.1 Non-profit Institutions
2.4.2 Hospitals and Clinic
2.5 Anti-Venom Sales by Application
2.5.1 Global Anti-Venom Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Venom Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Venom Sale Price by Application (2017-2022)
3 Global Anti-Venom by Company
3.1 Global Anti-Venom Breakdown Data by Company
3.1.1 Global Anti-Venom Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Venom Sales Market Share by Company (2020-2022)
3.2 Global Anti-Venom Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Venom Revenue by Company (2020-2022)
3.2.2 Global Anti-Venom Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Venom Sale Price by Company
3.4 Key Manufacturers Anti-Venom Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Venom Product Location Distribution
3.4.2 Players Anti-Venom Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Venom by Geographic Region
4.1 World Historic Anti-Venom Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Venom Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Venom Annual Revenue by Geographic Region
4.2 World Historic Anti-Venom Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Venom Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Venom Annual Revenue by Country/Region
4.3 Americas Anti-Venom Sales Growth
4.4 APAC Anti-Venom Sales Growth
4.5 Europe Anti-Venom Sales Growth
4.6 Middle East & Africa Anti-Venom Sales Growth
5 Americas
5.1 Americas Anti-Venom Sales by Country
5.1.1 Americas Anti-Venom Sales by Country (2017-2022)
5.1.2 Americas Anti-Venom Revenue by Country (2017-2022)
5.2 Americas Anti-Venom Sales by Type
5.3 Americas Anti-Venom Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Venom Sales by Region
6.1.1 APAC Anti-Venom Sales by Region (2017-2022)
6.1.2 APAC Anti-Venom Revenue by Region (2017-2022)
6.2 APAC Anti-Venom Sales by Type
6.3 APAC Anti-Venom Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Venom by Country
7.1.1 Europe Anti-Venom Sales by Country (2017-2022)
7.1.2 Europe Anti-Venom Revenue by Country (2017-2022)
7.2 Europe Anti-Venom Sales by Type
7.3 Europe Anti-Venom Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Venom by Country
8.1.1 Middle East & Africa Anti-Venom Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Venom Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Venom Sales by Type
8.3 Middle East & Africa Anti-Venom Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Venom
10.3 Manufacturing Process Analysis of Anti-Venom
10.4 Industry Chain Structure of Anti-Venom
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Venom Distributors
11.3 Anti-Venom Customer
12 World Forecast Review for Anti-Venom by Geographic Region
12.1 Global Anti-Venom Market Size Forecast by Region
12.1.1 Global Anti-Venom Forecast by Region (2023-2028)
12.1.2 Global Anti-Venom Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Venom Forecast by Type
12.7 Global Anti-Venom Forecast by Application
13 Key Players Analysis
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Anti-Venom Product Offered
13.1.3 CSL Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Anti-Venom Product Offered
13.2.3 Merck Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 BTG
13.3.1 BTG Company Information
13.3.2 BTG Anti-Venom Product Offered
13.3.3 BTG Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BTG Main Business Overview
13.3.5 BTG Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Anti-Venom Product Offered
13.4.3 Pfizer Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Haffkine Bio-Pharmaceutical
13.5.1 Haffkine Bio-Pharmaceutical Company Information
13.5.2 Haffkine Bio-Pharmaceutical Anti-Venom Product Offered
13.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Haffkine Bio-Pharmaceutical Main Business Overview
13.5.5 Haffkine Bio-Pharmaceutical Latest Developments
13.6 Rare Disease Therapeutics
13.6.1 Rare Disease Therapeutics Company Information
13.6.2 Rare Disease Therapeutics Anti-Venom Product Offered
13.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Rare Disease Therapeutics Main Business Overview
13.6.5 Rare Disease Therapeutics Latest Developments
13.7 Flynn Pharma
13.7.1 Flynn Pharma Company Information
13.7.2 Flynn Pharma Anti-Venom Product Offered
13.7.3 Flynn Pharma Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Flynn Pharma Main Business Overview
13.7.5 Flynn Pharma Latest Developments
13.8 Vins Bioproducts
13.8.1 Vins Bioproducts Company Information
13.8.2 Vins Bioproducts Anti-Venom Product Offered
13.8.3 Vins Bioproducts Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Vins Bioproducts Main Business Overview
13.8.5 Vins Bioproducts Latest Developments
13.9 Bharat Serums and Vaccines
13.9.1 Bharat Serums and Vaccines Company Information
13.9.2 Bharat Serums and Vaccines Anti-Venom Product Offered
13.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bharat Serums and Vaccines Main Business Overview
13.9.5 Bharat Serums and Vaccines Latest Developments
13.10 Serum Biotech
13.10.1 Serum Biotech Company Information
13.10.2 Serum Biotech Anti-Venom Product Offered
13.10.3 Serum Biotech Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Serum Biotech Main Business Overview
13.10.5 Serum Biotech Latest Developments
13.11 MicroPharm
13.11.1 MicroPharm Company Information
13.11.2 MicroPharm Anti-Venom Product Offered
13.11.3 MicroPharm Anti-Venom Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 MicroPharm Main Business Overview
13.11.5 MicroPharm Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Anti-Venom Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Venom Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Polyvalent Anti-Venom
Table 4. Major Players of Monovalent Anti-Venom
Table 5. Global Anti-Venom Sales by Type (2017-2022) & (K Vials)
Table 6. Global Anti-Venom Sales Market Share by Type (2017-2022)
Table 7. Global Anti-Venom Revenue by Type (2017-2022) & ($ million)
Table 8. Global Anti-Venom Revenue Market Share by Type (2017-2022)
Table 9. Global Anti-Venom Sale Price by Type (2017-2022) & (USD/Vial)
Table 10. Global Anti-Venom Sales by Application (2017-2022) & (K Vials)
Table 11. Global Anti-Venom Sales Market Share by Application (2017-2022)
Table 12. Global Anti-Venom Revenue by Application (2017-2022)
Table 13. Global Anti-Venom Revenue Market Share by Application (2017-2022)
Table 14. Global Anti-Venom Sale Price by Application (2017-2022) & (USD/Vial)
Table 15. Global Anti-Venom Sales by Company (2020-2022) & (K Vials)
Table 16. Global Anti-Venom Sales Market Share by Company (2020-2022)
Table 17. Global Anti-Venom Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Anti-Venom Revenue Market Share by Company (2020-2022)
Table 19. Global Anti-Venom Sale Price by Company (2020-2022) & (USD/Vial)
Table 20. Key Manufacturers Anti-Venom Producing Area Distribution and Sales Area
Table 21. Players Anti-Venom Products Offered
Table 22. Anti-Venom Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti-Venom Sales by Geographic Region (2017-2022) & (K Vials)
Table 26. Global Anti-Venom Sales Market Share Geographic Region (2017-2022)
Table 27. Global Anti-Venom Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Anti-Venom Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Anti-Venom Sales by Country/Region (2017-2022) & (K Vials)
Table 30. Global Anti-Venom Sales Market Share by Country/Region (2017-2022)
Table 31. Global Anti-Venom Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Anti-Venom Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Anti-Venom Sales by Country (2017-2022) & (K Vials)
Table 34. Americas Anti-Venom Sales Market Share by Country (2017-2022)
Table 35. Americas Anti-Venom Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Anti-Venom Revenue Market Share by Country (2017-2022)
Table 37. Americas Anti-Venom Sales by Type (2017-2022) & (K Vials)
Table 38. Americas Anti-Venom Sales Market Share by Type (2017-2022)
Table 39. Americas Anti-Venom Sales by Application (2017-2022) & (K Vials)
Table 40. Americas Anti-Venom Sales Market Share by Application (2017-2022)
Table 41. APAC Anti-Venom Sales by Region (2017-2022) & (K Vials)
Table 42. APAC Anti-Venom Sales Market Share by Region (2017-2022)
Table 43. APAC Anti-Venom Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Anti-Venom Revenue Market Share by Region (2017-2022)
Table 45. APAC Anti-Venom Sales by Type (2017-2022) & (K Vials)
Table 46. APAC Anti-Venom Sales Market Share by Type (2017-2022)
Table 47. APAC Anti-Venom Sales by Application (2017-2022) & (K Vials)
Table 48. APAC Anti-Venom Sales Market Share by Application (2017-2022)
Table 49. Europe Anti-Venom Sales by Country (2017-2022) & (K Vials)
Table 50. Europe Anti-Venom Sales Market Share by Country (2017-2022)
Table 51. Europe Anti-Venom Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Anti-Venom Revenue Market Share by Country (2017-2022)
Table 53. Europe Anti-Venom Sales by Type (2017-2022) & (K Vials)
Table 54. Europe Anti-Venom Sales Market Share by Type (2017-2022)
Table 55. Europe Anti-Venom Sales by Application (2017-2022) & (K Vials)
Table 56. Europe Anti-Venom Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Anti-Venom Sales by Country (2017-2022) & (K Vials)
Table 58. Middle East & Africa Anti-Venom Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Anti-Venom Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Anti-Venom Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Anti-Venom Sales by Type (2017-2022) & (K Vials)
Table 62. Middle East & Africa Anti-Venom Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Anti-Venom Sales by Application (2017-2022) & (K Vials)
Table 64. Middle East & Africa Anti-Venom Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Anti-Venom
Table 66. Key Market Challenges & Risks of Anti-Venom
Table 67. Key Industry Trends of Anti-Venom
Table 68. Anti-Venom Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Anti-Venom Distributors List
Table 71. Anti-Venom Customer List
Table 72. Global Anti-Venom Sales Forecast by Region (2023-2028) & (K Vials)
Table 73. Global Anti-Venom Sales Market Forecast by Region
Table 74. Global Anti-Venom Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Anti-Venom Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Anti-Venom Sales Forecast by Country (2023-2028) & (K Vials)
Table 77. Americas Anti-Venom Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Anti-Venom Sales Forecast by Region (2023-2028) & (K Vials)
Table 79. APAC Anti-Venom Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Anti-Venom Sales Forecast by Country (2023-2028) & (K Vials)
Table 81. Europe Anti-Venom Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Anti-Venom Sales Forecast by Country (2023-2028) & (K Vials)
Table 83. Middle East & Africa Anti-Venom Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Anti-Venom Sales Forecast by Type (2023-2028) & (K Vials)
Table 85. Global Anti-Venom Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Anti-Venom Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Anti-Venom Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Anti-Venom Sales Forecast by Application (2023-2028) & (K Vials)
Table 89. Global Anti-Venom Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Anti-Venom Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Anti-Venom Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Anti-Venom Product Offered
Table 94. CSL Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 95. CSL Main Business
Table 96. CSL Latest Developments
Table 97. Merck Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Anti-Venom Product Offered
Table 99. Merck Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. BTG Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 103. BTG Anti-Venom Product Offered
Table 104. BTG Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 105. BTG Main Business
Table 106. BTG Latest Developments
Table 107. Pfizer Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Anti-Venom Product Offered
Table 109. Pfizer Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Haffkine Bio-Pharmaceutical Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 113. Haffkine Bio-Pharmaceutical Anti-Venom Product Offered
Table 114. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 115. Haffkine Bio-Pharmaceutical Main Business
Table 116. Haffkine Bio-Pharmaceutical Latest Developments
Table 117. Rare Disease Therapeutics Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 118. Rare Disease Therapeutics Anti-Venom Product Offered
Table 119. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 120. Rare Disease Therapeutics Main Business
Table 121. Rare Disease Therapeutics Latest Developments
Table 122. Flynn Pharma Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 123. Flynn Pharma Anti-Venom Product Offered
Table 124. Flynn Pharma Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 125. Flynn Pharma Main Business
Table 126. Flynn Pharma Latest Developments
Table 127. Vins Bioproducts Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 128. Vins Bioproducts Anti-Venom Product Offered
Table 129. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 130. Vins Bioproducts Main Business
Table 131. Vins Bioproducts Latest Developments
Table 132. Bharat Serums and Vaccines Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 133. Bharat Serums and Vaccines Anti-Venom Product Offered
Table 134. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 135. Bharat Serums and Vaccines Main Business
Table 136. Bharat Serums and Vaccines Latest Developments
Table 137. Serum Biotech Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 138. Serum Biotech Anti-Venom Product Offered
Table 139. Serum Biotech Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 140. Serum Biotech Main Business
Table 141. Serum Biotech Latest Developments
Table 142. MicroPharm Basic Information, Anti-Venom Manufacturing Base, Sales Area and Its Competitors
Table 143. MicroPharm Anti-Venom Product Offered
Table 144. MicroPharm Anti-Venom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 145. MicroPharm Main Business
Table 146. MicroPharm Latest Developments
List of Figures
Figure 1. Picture of Anti-Venom
Figure 2. Anti-Venom Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Venom Sales Growth Rate 2017-2028 (K Vials)
Figure 7. Global Anti-Venom Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-Venom Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Polyvalent Anti-Venom
Figure 10. Product Picture of Monovalent Anti-Venom
Figure 11. Global Anti-Venom Sales Market Share by Type in 2021
Figure 12. Global Anti-Venom Revenue Market Share by Type (2017-2022)
Figure 13. Anti-Venom Consumed in Non-profit Institutions
Figure 14. Global Anti-Venom Market: Non-profit Institutions (2017-2022) & (K Vials)
Figure 15. Anti-Venom Consumed in Hospitals and Clinic
Figure 16. Global Anti-Venom Market: Hospitals and Clinic (2017-2022) & (K Vials)
Figure 17. Global Anti-Venom Sales Market Share by Application (2017-2022)
Figure 18. Global Anti-Venom Revenue Market Share by Application in 2021
Figure 19. Anti-Venom Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Anti-Venom Revenue Market Share by Company in 2021
Figure 21. Global Anti-Venom Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Anti-Venom Revenue Market Share by Geographic Region in 2021
Figure 23. Global Anti-Venom Sales Market Share by Region (2017-2022)
Figure 24. Global Anti-Venom Revenue Market Share by Country/Region in 2021
Figure 25. Americas Anti-Venom Sales 2017-2022 (K Vials)
Figure 26. Americas Anti-Venom Revenue 2017-2022 ($ Millions)
Figure 27. APAC Anti-Venom Sales 2017-2022 (K Vials)
Figure 28. APAC Anti-Venom Revenue 2017-2022 ($ Millions)
Figure 29. Europe Anti-Venom Sales 2017-2022 (K Vials)
Figure 30. Europe Anti-Venom Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Anti-Venom Sales 2017-2022 (K Vials)
Figure 32. Middle East & Africa Anti-Venom Revenue 2017-2022 ($ Millions)
Figure 33. Americas Anti-Venom Sales Market Share by Country in 2021
Figure 34. Americas Anti-Venom Revenue Market Share by Country in 2021
Figure 35. United States Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Anti-Venom Sales Market Share by Region in 2021
Figure 40. APAC Anti-Venom Revenue Market Share by Regions in 2021
Figure 41. China Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Anti-Venom Sales Market Share by Country in 2021
Figure 48. Europe Anti-Venom Revenue Market Share by Country in 2021
Figure 49. Germany Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Anti-Venom Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Anti-Venom Revenue Market Share by Country in 2021
Figure 56. Egypt Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Anti-Venom Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Anti-Venom in 2021
Figure 62. Manufacturing Process Analysis of Anti-Venom
Figure 63. Industry Chain Structure of Anti-Venom
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
